Last week, a Federal Court jury in Florida found Boston Scientific liable for the severe personal injuries caused by one of its transvaginal mesh products. The Florida case involved four women suffering tremendous problems from implanted mesh. The jury assessed $26.7 Million in damages against the company. This was not the first trial loss

We are presently representing clients who have been injured by several different defective medical products, including the diabetes drug Actos and transvaginal mesh. As part of our work, we have studied much of the available medical research.

Recently, I viewed an interesting discussion on an issue important in the medical research. The issue is:

Recent decisions from the U.S. Supreme Court have allowed generic drug manufacturers to escape justice for the personal injuries and deaths caused by their dangerous and defective products. It is unjust that any company could market a defective product and not be accountable for the harm it causes. Yet, our law now provides generic drug manufacturers